Biocept to explore strategic alternatives and implement restructuring plan

San diego--( business wire )--biocept, inc. (nasdaqcm: bioc) today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value. biocept has engaged ef hutton, division of benchmark investments, inc., as its financial advisor to assist in this process.
BIOC Ratings Summary
BIOC Quant Ranking